Oncology Test Menu
Solid Tumor Analysis	Diagnostic Consultation Immunohistochemistry Antibodies Technical Component or Consultation Actin, Pan Muscle (hhf35) Alpha-1-Antichymotrypsin (A1ACT) Alpha-1-Antitrypsin (A1AT) Alpha-Fetoprotein (AFP) AMACR, Alpha-methylacyl-CoA Racemase Anaplastic Lymphoma Kinase (ALK-1) B72.3 BCL-1 (Cyclin D-1) BCL-2 Ber-EP4 CA 125 (OC125) Calcitonin Calponin Calretinin Carcinoembryonic Antigen (CEA, monoclonal) Carcinoembryonic Antigen (CEA, polyclonal) Cathepsin D (CATH-D) CD1a CD3 CD4 CD5 CD7 CD8 CD10 (CALLA) CD 15 (Leu-M1) CD20 (L26) CD23 CD25 CD 30 (Ber-H2, Ki-1) CD31 CD34 CD43 (MT1) CD45 (CD45RB, LCA) CD57 (Leu-7) CD61 (GPIIIa) CD68 (PG-M1, KP1) CD79a CD99 (MIC2) CD117 (C-kit) CD138 (Syndecan-1) Chromogranin CK903, P504S, P63 cocktail Collagen Type IV Cyclin D-1 (BCL-1) Cyclin E Cytokeratin 5/6 Cytokeratin 7 Cytokeratin 20 Cytokeratin 903 (34BetaE12, HMW) Cytokeratin AE1/AE3 Cytokeratin CAM 5.2 Cytokeratin PAN K Cytomegalovirus Desmin E-Cadherin Epidermal Growth Factor Receptor (EGFR) Epithelial Membrane Antigen (EMA) Estrogen Receptor (ER) Factor VIII Factor XIIIa Fascin GCDFP-15 (BRST-2) Glial Fibrillary Acidic Protein (GFAP) Glycophorin A (Erythroid Cells) Ham 56 (Macrophages) HBME-1 (Mesothelial Antigen) Helicobacter pylori Hepatitis B Core Antigen Hepatitis B Surface Antigen HepPar 1 (Hepatic Carcinoma Marker) HER-2/neu (c-erb B2) HercepTest® Herpes Simplex Virus (HSV) Types I & II HMB-45 hMLH-1 (DNA repair enzyme) hMSH-2 (DNA repair enzyme) Human Chorionic Gonadotropin (HCG) Human Papillomavirus (HPV) Immunoglobulin A Heavy Chain (IgA) Immunoglobulin G Heavy Chain (IgG) Immunoglobulin M Heavy Chain (IgM) Inhibin Kappa Light Chain Ki-67 (MIB-1) Lambda Light Chain Lysozyme Mast Cell Tryptase Melan A (A103) Melan A (A103) with DAB MOC31 (Adenocarcinoma Marker) Multiple Myeloma Oncogene-1 Myeloperoxidase Myoglobin Neurofilament Neuron Specific Enolase p27 (Kip1) p53 p63 Pan Cytokeratin Placental Alkaline Phosphatase Placental Lactogen (hPL) Pneumocystis carinii Progesterone Receptor (PR) Promyelocytic Leukemia Protein Prostate-Specific Antigen (monoclonal) Prostate-Specific Antigen (polyclonal) Prostatic Acid Phosphatase (monoclonal) Prostatic Acid Phosphatase (polyclonal) Protein Gene Product (PGP) pS2 (ER related protein) S-100 Protein with APR S-100 Protein with DAB Smooth Muscle Actin (1A4, alpha) Smooth Muscle Myosin, Heavy Chain Synaptophysin Terminal Deoxynucleotidyl Transferase (TdT) Thyroglobulin Thyroid Transcription Factor-1 Villin Vimentin Wilm’s Tumor 1 (WT1)
	Prognostic/Therapeutic Markers Estrogen Receptor (ER) Progesterone Receptor (PR) HER-2/neu (c-erb B2) HercepTest® Ki-67 (MIB-1) pS2 (ER related protein) p53 Epidermal Growth Factor Receptor (EGFR) Cathepsin D (CATH-D) HER-2/neu by FISH DNA Analysis by Flow Cytometry and Image Analysis
	Colon Cancer Studies HNPCC (DNA Mismatch Repair) Profile: hMLH-1 hMSH-2 EGFR pharmDx™
	Lymph Node Micrometastasis Carcinoma (AE1/AE3, H&E, CAM 5.2, H&E, PAN K) Melanoma (HMB-45, H&E, S-100, H&E and Melan)
	Cytogenetics/Karyotype Analysis Solid Tumor Effusion
	Urology Special Studies ImmunoCyt™ (includes Urine Cytology) UroVysion™
	Detection of Infectious Agents HPV, high- and low-risk, by Hybrid Capture II® HPV, high-risk only, by Hybrid Capture II® HPV, high- and low-risk, by Chromogenic In Situ Hybridization (Tissue) HPV, high-risk only, by Chromogenic In Situ Hybridization (Tissue) Chlamydia trachomatis by PCR Neisseria gonorrheae by PCR Herpes Simplex Virus by PCR
Hematopathology	Diagnostic Consultation Morphologic Evaluation (Bone Marrow, Lymphoid Tissue)
	Flow Cytometry Immunophenotyping
	Cytogenetics/Karyotype Analysis Leukemic Blood for Hematologic Disorders Bone Marrow Aspirate Lymph Node Bone Marrow Biopsy
	FISH PROBES/PROFILES CHROMOSOME/ GENE ABNORMALITY DETECTED Acute Myeloid Leukemia M3 subset PML/RARA t(15;17) Acute Myeloid Leukemia M2 subset AML1/ETO t(8;21) Acute Myeloid Leukemia M4Eo MYH11/CBFB inv(16)/t(16;16) AML/High-Grade MDS AML1/ETO t(8;21) CBFB inv(16)/t(16;16)   BCR/ABL1 t(9;22)   5q -5/5q deletion   7q -7/7q deletion   8 +8   MLL 11q23 rearrangements 20q 20q deletion Low-Grade MDS 5q -5/5q deletion   7q -7/7q deletion   8 +8   MLL 11q23 rearrangements 20q 20q deletions Chronic Myeloid Leukemia BCR/ABL1 t(9;22) 9q34 del(9)(q34) Chronic Lymphocytic Leukemia p53 17p deletion   ATM 11q deletion   12 +12   13q14 (D13S319) 13q deletion 13q34 13q deletion Multiple Myeloma IGH/14q32     IGH/CCND1 t(11;14)   IGH/FGFR3 t(4;14)   IGH/MAF t(14;16)   13q14 (D13S319) 13q deletion   13q34 13q deletion   p53 17p deletion 5/9/15 aneuploidy Follicular Lymphoma IGH/BCL-2 t(14;18) Mantle Cell Lymphoma IGH/CCND1 BCL-1; t(11;14) Burkitt Lymphoma IGH/MYC t(8;14) MALT Lymphoma API2/MALT1 t(11;18)   IGH/MALT1 t(14;18)   3 +3   MALT1 18q21 rearrangements
	Polymerase Chain Reaction (PCR) JAK2 V617F Mutation bcr/abl Quantitative RT-PCR pml/rara RT-PCR B-Cell Gene Rearrangement T-Cell Gene Rearrangement